MedTrace Logo

Augmenting Treatment Effects of Voice Therapy in Parkinson Disease

NCT02265315 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2020-09-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of a non-invasive brain stimulation technique called transcranial magnetic stimulation (TMS) on voice/speech treatment in people with Parkinson's Disease (PD), through the use of speech and voice analysis, examination of voice box, and brain imaging methods.

Conditions

  • Parkinson Disease

Interventions

OTHER

Transcranial Magnetic Stimulation

Treament adjuvant applied to accelerate vocal motor learning and overall voice improvement

BEHAVIORAL

Lee Silverman Voice Treatment

Time intensive behavioral treatment for Parkinson's hypophonia

Sponsors & Collaborators

  • Michael J. Fox Foundation for Parkinson's Research

    collaborator OTHER

  • University of Tennessee

    collaborator OTHER

  • University of Memphis

    collaborator OTHER

  • Le Bonheur Children's Hospital

    lead OTHER

Principal Investigators

  • Shalini Narayana, PhD · LeBonheur Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2020-12-31
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02265315 on ClinicalTrials.gov